The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Gold Prices Ease as Markets Await Key U.S. Inflation Data and Fed Rate Outlook
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
DOJ Pushes to Resume Trump White House Ballroom Project After Security Incident
Intesa Sanpaolo Launches €30.6 Billion Bid for Monte dei Paschi to Drive Italian Banking Consolidation
Goldman Sachs to Pay $500M in 1MDB Shareholder Fraud Settlement
US Stocks Rebound as Iran Eases Military Operations; Tech Shares Lead Wall Street Recovery
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
US Stock Futures Slip as New Iran Strikes Weigh on Market Sentiment Ahead of Inflation Data
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
DOJ Sues UCLA Over Alleged Antisemitism and Hostile Campus Environment
Italy’s ITA Airways Weighs Legal Action Against Pratt & Whitney Over Grounded Airbus Fleet
BitGo Expands Regulated Crypto Trading Services in MENA
New Zealand Unemployment and Inflation Debate Intensifies Ahead of 2026 Election
Why the future of marijuana legalization remains hazy despite high public support
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Apple Unveils Enhanced Apple Intelligence and Next-Generation Siri at WWDC 2026 



